[HTML][HTML] IL-1β and the intestinal epithelial tight junction barrier

LW Kaminsky, R Al-Sadi, TY Ma - Frontiers in immunology, 2021 - frontiersin.org
The intestinal epithelial tight junction (TJ) barrier controls the paracellular permeation of
contents from the intestinal lumen into the intestinal tissue and systemic circulation. A …

Epithelial Toll-like receptors and their role in gut homeostasis and disease

JF Burgueño, MT Abreu - Nature Reviews Gastroenterology & …, 2020 - nature.com
The human gastrointestinal tract is colonized by trillions of microorganisms that interact with
the host to maintain structural and functional homeostasis. Acting as the interface between …

[HTML][HTML] Translocation of viable gut microbiota to mesenteric adipose drives formation of creeping fat in humans

CWY Ha, A Martin, GD Sepich-Poore, B Shi, Y Wang… - Cell, 2020 - cell.com
A mysterious feature of Crohn's disease (CD) is the extra-intestinal manifestation of"
creeping fat"(CrF), defined as expansion of mesenteric adipose tissue around the inflamed …

Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway

L Liang, L Liu, W Zhou, C Yang, G Mai, H Li… - Clinical …, 2022 - portlandpress.com
Ulcerative colitis (UC) is majorly associated with dysregulation of the dynamic cross-talk
among microbial metabolites, intestinal epithelial cells, and macrophages. Several studies …

[HTML][HTML] The role of intestinal permeability in gastrointestinal disorders and current methods of evaluation

T Vanuytsel, J Tack, R Farre - Frontiers in Nutrition, 2021 - frontiersin.org
An increased intestinal permeability has been described in various gastrointestinal and non-
gastrointestinal disorders. Nevertheless, the concept and definition of intestinal permeability …

[HTML][HTML] Gut microbiome and aging: Physiological and mechanistic insights

R Nagpal, R Mainali, S Ahmadi, S Wang… - … and healthy aging, 2018 - content.iospress.com
The development of human gut microbiota begins as soon as the neonate leaves the
protective environment of the uterus (or maybe in-utero) and is exposed to innumerable …

Kaempferol reduces obesity, prevents intestinal inflammation, and modulates gut microbiota in high-fat diet mice

Y Bian, J Lei, J Zhong, B Wang, Y Wan, J Li… - The Journal of …, 2022 - Elsevier
Kaempferol, a flavonoid identified in a wide variety of dietary sources, has been reported to
possess anti-obesity properties; however, its underlying mechanism was poorly understood …

[HTML][HTML] A treat-to-target update in ulcerative colitis: a systematic review

R Ungaro, JF Colombel, T Lissoos… - Official journal of the …, 2019 - journals.lww.com
OBJECTIVES: In 2015, the Selecting Therapeutic Targets in Inflammatory Bowel Disease
(STRIDE) program proposed shifting the therapeutic focus on ulcerative colitis (UC) toward …

consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases

N Mitrev, N Vande Casteele, CH Seow… - Alimentary …, 2017 - Wiley Online Library
Background Therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD)
patients receiving anti‐tumour necrosis factor (TNF) agents can help optimise outcomes …

Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease

H Leibovitzh, SH Lee, M Xue, JAR Garay… - Gastroenterology, 2022 - Elsevier
Background & Aims The gut microbiome has been suggested to play a role in gut barrier
hemostasis, but data are scarce and limited to animal studies. We therefore aimed to assess …